Chang, Ken <br/><br/>
Multimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab.  [electronic resource] 

 -  Neuro-oncology  12 2016 
 - 1680-1687 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-5866 
<br/><br/><label>Standard No.: </label>10.1093/neuonc/now086  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--therapeutic use<br/>Bevacizumab--therapeutic use<br/>Biomarkers<br/>Brain Neoplasms--diagnostic imaging<br/>Diffusion Magnetic Resonance Imaging--methods<br/>Disease-Free Survival<br/>Female<br/>Glioblastoma--diagnostic imaging<br/>Humans<br/>Image Interpretation, Computer-Assisted<br/>Magnetic Resonance Imaging--methods<br/>Male<br/>Middle Aged<br/>Multimodal Imaging--methods<br/>Proportional Hazards Models<br/>Survival Analysis<br/>Tumor Burden